Steward Partners Investment Advisory, LLC Intercept Pharmaceuticals, Inc. Transaction History

Steward Partners Investment Advisory, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$39.09 - $53.44 $1,368 - $1,870	-35 Closed	0 $0
Q2 2020 Aug 06, 2020	SELL	$46.7 - $92.04 $1,868 - $3,681	-40 Reduced 53.33%	35 $2,000
Q4 2019 Jan 17, 2020	SELL	$57.36 - $124.1 $11,472 - $24,820	-200 Reduced 72.73%	75 $9,000
Q3 2019 Oct 30, 2019	BUY	$58.69 - $80.46 $11,738 - $16,091	200 Added 266.67%	275 $18,000
Q2 2019 Jul 25, 2019	BUY	$77.77 - $120.68 $5,832 - $9,051	75 New	75 $5,000
Q4 2018 Jan 15, 2019	SELL	$85.79 - $126.46 $12,182 - $17,957	-142 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$60.0 - $85.67 $3,240 - $4,626	54 Added 61.36%	142 $12,000
Q1 2018 Apr 20, 2018	SELL	$52.72 - $67.25 $3,532 - $4,505	-67 Reduced 43.23%	88 $5,000
Q3 2017 Nov 22, 2017	SELL	$57.01 - $118.75 $627 - $1,306	-11 Reduced 6.63%	155 $8,000
Q1 2017 Nov 22, 2017	BUY	N/A	166	166 $18,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.